[VRDN] QoQ Quarter Result on 31-Mar-2024 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
08-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 27.40%
YoY- 28.66%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 86 72 72 72 72 72 98 -8.31%
PBT -76,689 -64,993 -48,542 -66,860 -47,660 -55,063 -68,151 8.16%
Tax 0 0 -145 5,534 -135 4,378 -105 -
NP -76,689 -64,993 -48,542 -66,860 -47,660 -55,063 -68,046 8.27%
Tax Rate - - - - - - - -
Total Cost 76,775 65,065 48,614 66,932 47,732 55,135 68,144 8.25%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -89,173.26 -90,268.05 -67,419.44 -92,861.11 -66,194.44 -76,476.39 -69,434.69 18.09%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -1.15 -1.02 -0.79 -1.35 -1.09 -1.27 -1.61 -20.04%
EPS Diluted -1.15 -1.02 -0.79 -1.35 -1.09 -1.27 -1.61 -20.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.